Oscar Health (OSCR) risk factors, FY2025 10-K

Oscar Health's FY2025 10-K, filed Feb 13, 2026, lists 41 risk factors in 4 groups. Against the prior year's 43: 5 new, 7 dropped, 20 substantially reworded.

Risk factors listed
414 groups
New this year
5vs 43 last year
Dropped
7since the prior 10-K
Substantially reworded
20of those kept
Section length
30k wordsItem 1A

What the changes say

  • Oscar Health's risk profile centers heavily on regulatory and legislative uncertainties affecting ACA plans, including program integrity rules and premium tax credits.
  • The company also highlights risks from its acquisition of IHC Specialty Benefits, potential tariff impacts, and debt conversion terms.

What changed since the prior 10-K

New

  • New

    The Program Integrity Rules, as well as the OBBBA, could have a material impact on the Health Insurance Marketplaces and could also have a material impact on our membership, business, revenue, operating results, and financial condition

    Program Integrity Rules, the OBBBA, and potential eAPTC extensions or expirations create operational disruptions and enrollment shifts for our Health Insurance Marketplaces.

  • NewRisks Related to the Regulatory Framework that Governs Us

    Furthermore, we may face challenges prioritizing the allocation of resources between implementing systems responsive to new legislative or regulatory requirements and focusing on growth-related operations

    Allocating resources between new regulatory compliance and growth operations creates challenges, alongside risks from handling personal and medical data.

  • NewRisks Related to the Regulatory Framework that Governs Us

    Changes in laws, regulations or rules relating to taxes or tariffs could adversely affect us

    The OBBBA's tax provisions and potential tariffs on imported pharmaceuticals and medical devices could adversely affect our business and cash flows.

  • NewRisks Related to our Business

    Our acquisition and ownership of a health insurance agency and an enhanced direct enrollment platform exposes us to risks that could adversely affect our business, financial condition, results of operations, and cash flows

    Acquiring IHC Specialty Benefits exposes us to agency-specific operational, regulatory, and financial risks, including reliance on carrier commission payments.

  • NewRisks Related to our Indebtedness

    We may be unable to raise the funds necessary to repurchase our outstanding Notes for cash following a fundamental change or on the optional repurchase dates, or to pay any cash amounts due upon conversion, and our other indebtedness may limit our ability to repurchase the Notes or pay cash upon their conversion

    We may lack sufficient cash or financing to repurchase our outstanding Notes or pay cash conversion amounts upon a fundamental change.

Dropped

  • Dropped

    impact our financial condition or require a change in our operating strategies. As a result of these factors, entering new markets or introducing new health plans may decrease our profitability

  • DroppedRisks Related to the Regulatory Framework that Governs Us

    We operate in a highly regulated industry and we must comply with numerous and complex state and federal laws and regulations to operate our business, including requirements to maintain or renew our regulatory approvals or obtain new regulatory approvals to sell insurance and to sell specific health plans

  • DroppedRisks Related to the Regulatory Framework that Governs Us

    Changes to government policies (including those not specifically targeted to the healthcare industry), such as a change in tax laws and the corporate tax rate, premium tax rate, or government spending cuts, could have significant impacts on our business, results of operations, financial condition and liquidity

    Risks of entering new markets or introducing new health plans decreasing profitability.

  • DroppedRisks Related to the Regulatory Framework that Governs Us

    knew, or it is determined that we should have known, that information we provided to form the basis for a claim for government payment was false or fraudulent, or that we were out of compliance with program requirements considered material to the government’s payment decision

  • DroppedRisks Related to the Regulatory Framework that Governs Us

    Health insurers are required to maintain compliance programs to prevent, detect and remediate fraud, waste, and abuse, and are often the subject of fraud, waste, and abuse investigations and audits

  • DroppedRisks Related to our Business

    number of highly-specialized insurance experts, the loss of any one of whom could also have a disproportionate impact on our business. We face significant competition for personnel across all areas of our business, and we may not be able to replace key personnel in a timely manner or at all

  • DroppedRisks Related to Ownership of Our Class A Common Stock

    The obligations associated with being a public company require significant resources and management attention

    NAIC Model Audit Rule compliance and related corporate governance requirements.

Reworded

  • 89% rewrittenRisks Related to the Regulatory Framework that Governs Us

    We are subject to extensive fraud, waste, and abuse laws that may require us to take remedial measures or give rise to lawsuits, audits, investigations and claims against us, the outcome of which may have a material adverse effect on our business, financial condition, cash flows, or results of operations

    Retained the core fraud, waste, and abuse risk disclosure with minor stylistic formatting changes.

  • 79% rewritten

    Our strategy includes, without limitation, acquiring new members, retaining existing members, introducing new products and plans, expanding into new markets and lines of business, and monetizing our technology through our +Oscar platform

    Updated to explicitly reference our +Oscar platform as part of our strategy to monetize technology.

    Was: Our strategy includes, without limitation, acquiring new members and retaining existing members, introducing new products and plans, expanding into new markets and lines of business, and monetizing our technology through our +Oscar platform

  • 75% rewrittenRisks Related to Ownership of Our Class A Common Stock

    We may issue shares of preferred stock in the future, which could make it difficult for another company to acquire us or could otherwise adversely affect holders of our Class A common stock, which could depress the price of our Class A common stock

    Added specific language stating that potential preferred stock issuances may delay or prevent a change in control and depress Class A stock prices.

  • 74% rewritten

    Any changes to the ACA and its regulations could materially and adversely affect our business, results of operations, and financial condition

    Updated ACA revenue dependency to 98% for recent periods and added risks regarding judicial opinions and appointed official proposals.

  • 69% rewritten

    Failure to accurately estimate our incurred medical expenses or overall market morbidity, or effectively manage our medical costs or related administrative costs could negatively affect our financial position, results of operations, and cash flows

    Added explicit references to estimating future market morbidity and risk adjustment transfers, noting risks from incomplete underlying data.

    Was: Failure to accurately estimate our incurred medical expenses or effectively manage our medical costs or related administrative costs could negatively affect our financial position, results of operations, and cash flows

  • 68% rewrittenRisks Related to Ownership of Our Class A Common Stock

    We are a “controlled company” within the meaning of the rules of NYSE and, as a result, we may rely on exemptions from certain corporate governance requirements and, if we chose to do so, you will not have the same protections afforded to stockholders of companies that are not exempt from such requirements

    Retained controlled company risk disclosures under NYSE rules without substantive textual changes.

  • 65% rewritten

    The result of risk adjustment programs may impact our revenue, add operational complexity, and introduce additional uncertainties that may have a material adverse effect on our results of operations, financial condition, and cash flows

    Clarified that risk adjustment program estimates rely on data received from independent third parties.

    Was: The result of risk adjustment programs may impact our revenue, add operational complexity, and introduce additional uncertainties that have a material adverse effect on our results of operations, financial condition, and cash flows

  • 61% rewrittenRisks Related to our Business

    We rely on the experience and expertise of our Chief Executive Officer, Co-Founders, senior management team, highly-specialized technology and insurance experts, key technical employees, and other highly skilled personnel

    Added defined terms for Co-Founders Mario Schlosser and Joshua Kushner alongside CEO Mark T. Bertolini.

  • 59% rewrittenRisks Related to our Indebtedness

    Our debt obligations contain restrictions that impact our business and expose us to risks that could materially adversely affect our liquidity and financial condition

  • 56% rewrittenRisks Related to our Indebtedness

    Restrictions imposed by our 2026 Revolving Credit Facility may materially limit our ability to operate our business and finance our future operations or capital needs

    Was: Restrictions imposed by our Revolving Credit Facility may materially limit our ability to operate our business and finance our future operations or capital needs

  • 52% rewritten

    We have a history of losses, and we may not achieve or maintain profitability in the future

    Was: We have a history of losses, and we may not maintain profitability in the future

  • 46% rewrittenRisks Related to our Business

    We need liquidity to pay our operating expenses, make payments on our indebtedness, if any, and pay capital expenditures. The principal sources of our cash receipts are premiums, administrative fees, investment income, proceeds from borrowings and proceeds from the issuance of capital stock

  • 42% rewrittenRisks Related to our Indebtedness

    Provisions in the 2026 Revolving Credit Facility or the indentures governing the Notes could delay or prevent an otherwise beneficial takeover of us

    Was: Provisions in the Revolving Credit Facility or the Indenture governing the 2031 Notes could delay or prevent an otherwise beneficial takeover of us

  • 41% rewrittenRisks Related to our Business

    We may face risks associated with our utilization of certain AI and machine learning models

    Was: We may face risks associated with our utilization of certain artificial intelligence and machine learning models

  • 34% rewrittenRisks Related to our Business

    We are a public reporting company subject to the rules and regulations established by the SEC and the New York Stock Exchange (“NYSE”). These rules and regulations require, among other things, that we establish and periodically evaluate procedures with respect to our internal control over financial reporting

  • 31% rewrittenRisks Related to our Business

    We may not be able to utilize our net operating loss carryforwards (“NOLs”), to offset future taxable income for U.S. federal and state income tax purposes, which could adversely affect our cash flows

  • 29% rewrittenRisks Related to Ownership of Our Class A Common Stock

    If our operating and financial performance in any given period does not meet the guidance that we provide to the public, the market price of our Class A common stock may decline

  • 29% rewrittenRisks Related to our Business

    Failure to secure, protect, or enforce our intellectual property rights could harm our business, results of operations, and financial condition

  • 27% rewrittenRisks Related to our Business

    Our limited operating history in an evolving industry makes it difficult to evaluate our current business performance, implementation of our business model, and our future prospects

  • 20% rewrittenRisks Related to our Business

    If state regulators do not approve payments of dividends and distributions by our Health Insurance Subsidiaries to us, or do not approve other capital efficiency structures we may pursue, we may not have sufficient funds to implement our business strategy

All 41 risk factors

Headings as the filing states them, in filing order.

Other

  1. 01Our business, financial condition, and results of operations may be harmed if we fail to execute our strategy and manage our growth effectively
  2. 02Our strategy includes, without limitation, acquiring new members, retaining existing members, introducing new products and plans, expanding into new markets and lines of business, and monetizing our technology through our +Oscar platform79% rewritten
  3. 03The Program Integrity Rules, as well as the OBBBA, could have a material impact on the Health Insurance Marketplaces and could also have a material impact on our membership, business, revenue, operating results, and financial conditionNew
  4. 04Failure to accurately estimate our incurred medical expenses or overall market morbidity, or effectively manage our medical costs or related administrative costs could negatively affect our financial position, results of operations, and cash flows69% rewritten
  5. 05The result of risk adjustment programs may impact our revenue, add operational complexity, and introduce additional uncertainties that may have a material adverse effect on our results of operations, financial condition, and cash flows65% rewritten
  6. 06Any changes to the ACA and its regulations could materially and adversely affect our business, results of operations, and financial condition74% rewritten
  7. 07We have a history of losses, and we may not achieve or maintain profitability in the future52% rewritten

Risks Related to the Regulatory Framework that Governs Us

  1. 08Changes or developments in the regulation of health insurance markets in the United States, including passage and implementation of a law to create a single-payer or government-run health insurance program, could materially and adversely harm our business and operating results
  2. 09Furthermore, we may face challenges prioritizing the allocation of resources between implementing systems responsive to new legislative or regulatory requirements and focusing on growth-related operationsNew
  3. 10We are subject to extensive fraud, waste, and abuse laws that may require us to take remedial measures or give rise to lawsuits, audits, investigations and claims against us, the outcome of which may have a material adverse effect on our business, financial condition, cash flows, or results of operations89% rewritten
  4. 11Changes in laws, regulations or rules relating to taxes or tariffs could adversely affect usNew

Risks Related to our Business

  1. 12If state regulators do not approve payments of dividends and distributions by our Health Insurance Subsidiaries to us, or do not approve other capital efficiency structures we may pursue, we may not have sufficient funds to implement our business strategy20% rewritten
  2. 13We need liquidity to pay our operating expenses, make payments on our indebtedness, if any, and pay capital expenditures. The principal sources of our cash receipts are premiums, administrative fees, investment income, proceeds from borrowings and proceeds from the issuance of capital stock46% rewritten
  3. 14From time to time, we may become involved in costly and time-consuming litigation and regulatory audits and actions, which require significant attention from our management
  4. 15We are subject to risks associated with our geographic concentration
  5. 16We are subject to risks associated with outsourcing services and functions to third parties
  6. 17We rely on the experience and expertise of our Chief Executive Officer, Co-Founders, senior management team, highly-specialized technology and insurance experts, key technical employees, and other highly skilled personnel61% rewritten
  7. 18If we are unable to integrate and manage our information systems effectively, our operations could be disrupted
  8. 19Real or perceived errors, failures, vulnerabilities, or bugs in our systems, website, or app could impair our operations, damage our reputation and brand, and harm our business and operating results
  9. 20We may face risks associated with our utilization of certain AI and machine learning models41% rewritten
  10. 21We are subject to risks associated with public health crises arising from large-scale medical emergencies, pandemics, natural disasters and other extreme events, which have had, and could in the future have, an adverse effect on our business, results of operations, financial condition and financial performance
  11. 22We may not be able to utilize our net operating loss carryforwards (“NOLs”), to offset future taxable income for U.S. federal and state income tax purposes, which could adversely affect our cash flows31% rewritten
  12. 23Our limited operating history in an evolving industry makes it difficult to evaluate our current business performance, implementation of our business model, and our future prospects27% rewritten
  13. 24We are a public reporting company subject to the rules and regulations established by the SEC and the New York Stock Exchange (“NYSE”). These rules and regulations require, among other things, that we establish and periodically evaluate procedures with respect to our internal control over financial reporting34% rewritten
  14. 25Significant delays in our receipt of direct policy premiums, including as a result of regulatory restrictions on policy cancellations and non-renewals, could have a material adverse effect on our business, operations, cash flows, or earnings
  15. 26We make virtual healthcare services available to our members through Oscar Medical Group, in which we do not own any equity or voting interest, and our virtual care availability may be disrupted if our arrangements with providers like the Oscar Medical Group become subject to legal challenges
  16. 27Failure to secure, protect, or enforce our intellectual property rights could harm our business, results of operations, and financial condition29% rewritten
  17. 28We may be subject to claims by others that we are infringing on their intellectual property rights
  18. 29Increasing scrutiny and differing expectations with respect to sustainability and environmental, social and governance (“ESG”) matters may impose additional costs on us, impact our access to capital, or expose us to new or additional risks
  19. 30Our acquisition and ownership of a health insurance agency and an enhanced direct enrollment platform exposes us to risks that could adversely affect our business, financial condition, results of operations, and cash flowsNew

Risks Related to our Indebtedness

  1. 31Restrictions imposed by our 2026 Revolving Credit Facility may materially limit our ability to operate our business and finance our future operations or capital needs56% rewritten
  2. 32Our debt obligations contain restrictions that impact our business and expose us to risks that could materially adversely affect our liquidity and financial condition59% rewritten
  3. 33We may be unable to raise the funds necessary to repurchase our outstanding Notes for cash following a fundamental change or on the optional repurchase dates, or to pay any cash amounts due upon conversion, and our other indebtedness may limit our ability to repurchase the Notes or pay cash upon their conversionNew
  4. 34Provisions in the 2026 Revolving Credit Facility or the indentures governing the Notes could delay or prevent an otherwise beneficial takeover of us42% rewritten

Risks Related to Ownership of Our Class A Common Stock

  1. 35Because Thrive Capital and our Co-Founders’ interests may differ from those of our other stockholders, actions that Thrive Capital and our Co-Founders take with respect to us, as significant stockholders, may not be favorable to our other stockholders, including holders of our Class A common stock
  2. 36We cannot predict the effect our dual class structure may have on the market price of our Class A common stock
  3. 37We are a “controlled company” within the meaning of the rules of NYSE and, as a result, we may rely on exemptions from certain corporate governance requirements and, if we chose to do so, you will not have the same protections afforded to stockholders of companies that are not exempt from such requirements68% rewritten
  4. 38We do not intend to pay dividends on our Class A common stock for the foreseeable future
  5. 39We may issue shares of preferred stock in the future, which could make it difficult for another company to acquire us or could otherwise adversely affect holders of our Class A common stock, which could depress the price of our Class A common stock75% rewritten
  6. 40Anti-takeover provisions in our governing documents and under Delaware law could make an acquisition of the Company more difficult, limit attempts by our stockholders to replace or remove our current management, and depress the market price of our Class A common stock
  7. 41If our operating and financial performance in any given period does not meet the guidance that we provide to the public, the market price of our Class A common stock may decline29% rewritten

Other Oscar Health 10-Ks

  • FY2024 10-K risk factors
    43 risks

    Oscar Health achieved its first-ever profitability in 2024, reporting $26.1 million in net income and $199.2 million in Adjusted EBITDA, alongside an accumulated deficit of $2.85 billion.

    Filed Feb 20, 2025

About this page

The headings are the filing's own. The one-line readings and the overview are automated and can be wrong: read Item 1A of the 10-K for the exact wording.